[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335551-105":59,"doc-detail-335551-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","targeted-cancer-therapy-on-a-chip","Targeted Cancer Therapy-on-A-Chip","","Targeted cancer therapy (TCT) is attracting strong interest for reducing adverse side effects by specifically treating tumor cells. Traditional TCT testing relies on two-dimensional cell culture and animal studies, while organ-on-a-chip (OoC) platforms are used to recreate cancer in vitro as cancer-on-a-chip (CoC). This review evaluates CoC approaches for developing TCTs, identifying target biomarkers, and testing free versus encapsulated TCT formats, while addressing ongoing challenges toward bench-to-bedside translation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/targeted-cancer-therapy-on-a-chip/335551/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/targeted-cancer-therapy-on-a-chip/335551.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is targeted cancer therapy (TCT) gaining attention?","Question",{"text":112,"@type":113},"TCT aims to reduce risks of adverse side effects by specifically treating tumor cells, improving therapeutic specificity compared with conventional chemotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are the limitations of traditional TCT testing methods?",{"text":117,"@type":113},"TCT has typically been tested using 2D cell culture and animal studies, but 2D models fail to reproduce the in-vivo environment and animal models cannot accurately represent human responses.",{"name":119,"@type":110,"acceptedAnswer":120},"How do organ-on-a-chip platforms support TCT development and testing?",{"text":121,"@type":113},"Organ-on-a-chip systems recapitulate human tissues and organs on microfluidic devices, enabling dynamic flow conditions and biomimetic cancer-on-a-chip (CoC) models for developing and evaluating TCTs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335551,1790383946,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","[www.advhealthmat.de](www.advhealthmat.de)  \nTargeted Cancer Therapy-on-A-Chip  \nHeba Abed, Remya Radha, Shabana Anjum, Vinod Paul, Nour AlSawaftah, William G. Pitt, Nureddin Ashammakhi,* and Ghaleb A. Husseini*  \nTargeted cancer therapy (TCT) is gaining increased interest because it reduces the risks of adverse side eﬀects by speciﬁcally treating tumor cells. TCT testing has traditionally been performed using two-dimensional (2D) cell culture and animal studies. Organ-on-a-chip (OoC) platforms have been developed to recapitulate cancer in vitro, as cancer-on-a-chip (CoC), and used for chemotherapeutics development and testing. This review explores the use ofCoCs to both develop and test TCTs, with a focus on three main aspects, the use ofCoCs to identify target biomarkers for TCT development, the use of CoCs to test free, un-encapsulated TCTs, and the use ofCoCs to test encapsulated TCTs. Despite current challenges such as system scaling, and testing externally triggered TCTs, TCToC shows a promising future to serve asa supportive, pre-clinical platform to expedite TCT development and  \nbench-to-bedside translation.  \n1. Introduction  \nChemotherapy is one of the most prevalent treatments for cancer patients. [1] It is used as a primary treatment for patients with advanced metastatic cancers with no alternative treatment options, a neoadjuvant treatment prior to surgery, and an adjuvant treatment after surgery.[1] However, due to its low speciﬁcity, conventional chemotherapy is associated with unwanted toxic eﬀects leading to anemia, infection, gastrointestinal tract upset, and other problems that aﬀect the quality of life of patients. [2–10] To lower the risk of developing side effects, research focused on developing speciﬁc cancer therapies[11–14] such as targeted cancer therapy (TCT) . [11,13,15–17] Because of their high speciﬁcity[18] targeted therapies have already been shown to reduce  \nH. Abed, R. Radha, S. Anjum, G. A. Husseini Department of Chemical and Biological Engineering American University of Sharjah  \nSharjah, UAE  \nE-mail: [ghusseini@aus.edu](ghusseini@aus.edu)  \nV. Paul, N. AlSawaftah, G. A. Husseini Materials Science and Engineering PhD program College of Arts and Sciences  \nAmerican University of Sharjah Sharjah, UAE  \nW. G. Pitt  \nDepartment of Chemical Engineering Brigham Young University  \nProvo, UT 84602, USA  \nN. Ashammakhi  \nInstitute for Quantitative Health Science and Engineering (IQ) and Department of Biomedical Engineering (BME)  \nMichigan State University East Lansing, MI 48824, USA  \nE-mail: [n.ashammakhi@ucla.edu](n.ashammakhi@ucla.edu)  \nN. Ashammakhi  \nDepartment of Bioengineering University of California, Los Angeles Los Angeles, CA 90095-1600, USA  \nThe ORCID identiﬁcation number(s) for the author(s) of this article  \ncan be found under [https://doi.org/10.1002/adhm.202400833](https://doi.org/10.1002/adhm.202400833)[ ](https://doi.org/10.1002/adhm.202400833)© 2024 The Author(s). Advanced Healthcare Materials published by Wiley-VCH GmbH. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \nDOI: 10.1002/adhm.202400833  \nneutropenia,[19] mitigate oﬀ-target organ drug accumulation, and overcome multi-drug resistance (MDR) . [17,20–22] Moreover, a signiﬁcant advantage of TCTs is the ability to use higher doses of cytotoxic agents to achieve more eﬀective treatment. [16]  \nTo test TCT, two-dimensional (2D) cell culture[23–26] and experimental animals[27–31] have conventionally been used. In addition, the use of three-dimensional (3D) cultures, such as spheroids,[32–35] organoids,[32,33,36–40] tissue engineering,[41–44] and 3D bioprinting[45–49] constructs, have recently been explored as an alternative approach. [50–54] However, 2D cultures cannot reproduce the in vivo environment. [23,55,56] Organoids and spheroids are static models and suﬀer from ","cbCaitd5OfLxYa31","https://ap.wps.com/l/cbCaitd5OfLxYa31","pdf",5211686,35,"English","# Introduction\n## Rationale for targeted cancer therapy (TCT)\n## Limitations of conventional 2D models and animal studies\n## Emergence of organ-on-a-chip (OoC) and cancer-on-a-chip (CoC)\n## Review scope: biomarkers, free TCT testing, encapsulated TCT testing","[{\"question\":\"Why is targeted cancer therapy (TCT) gaining attention?\",\"answer\":\"TCT aims to reduce risks of adverse side effects by specifically treating tumor cells, improving therapeutic specificity compared with conventional chemotherapy.\"},{\"question\":\"What are the limitations of traditional TCT testing methods?\",\"answer\":\"TCT has typically been tested using 2D cell culture and animal studies, but 2D models fail to reproduce the in-vivo environment and animal models cannot accurately represent human responses.\"},{\"question\":\"How do organ-on-a-chip platforms support TCT development and testing?\",\"answer\":\"Organ-on-a-chip systems recapitulate human tissues and organs on microfluidic devices, enabling dynamic flow conditions and biomimetic cancer-on-a-chip (CoC) models for developing and evaluating TCTs.\"}]","Targeted Cancer Therapy-on-A-Chip | PDF",1790011416,88]